These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21439193)

  • 1. Asymptomatic COPD and NICE guidelines.
    Parkes G
    Br J Gen Pract; 2011 Apr; 61(585):294-5. PubMed ID: 21439193
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Guideline Highlights for the Hospitalist: The GOLD and NICE Guidelines for the Management of COPD.
    Neumeier A; Keith R
    J Hosp Med; 2020 Apr; 15(4):240-241. PubMed ID: 32118561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2010 NICE COPD Guidelines: how do they compare with the GOLD guidelines?
    Gruffydd-Jones K; Loveridge C
    Prim Care Respir J; 2011 Jun; 20(2):199-204. PubMed ID: 21437566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations of Polish Society of Lung Diseases about diagnosis and therapy of chronic obstructive pulmonary disease (COPD)].
    Pierzchała W; Barczyk A; Górecka D; Sliwiński P; Zieliński J;
    Pneumonol Alergol Pol; 2010; 78(5):318-47. PubMed ID: 20703997
    [No Abstract]   [Full Text] [Related]  

  • 5. What is unique about the new Canadian COPD guidelines?
    O'Donnell DE
    Can Respir J; 2004 Apr; 11(3):200-3. PubMed ID: 15124036
    [No Abstract]   [Full Text] [Related]  

  • 6. COPD 2020 Guidelines - what is new and why?
    Gupta N; Agrawal S; Chakrabarti S; Ish P
    Adv Respir Med; 2020; 88(1):38-40. PubMed ID: 32153009
    [No Abstract]   [Full Text] [Related]  

  • 7. NICE guidelines for chronic obstructive pulmonary disease--a review.
    Fehrenbach C
    Nurs Times; 2004 Jun 15-21; 100(24):48-51. PubMed ID: 15224493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial diagnosis and management of chronic obstructive pulmonary disease in Australia: views from the coal face.
    Bereznicki B; Walters H; Walters J; Peterson G; Bereznicki L
    Intern Med J; 2017 Jul; 47(7):807-813. PubMed ID: 28276136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What was the impact of the Spanish COPD guidelines (GesEPOC) and how can they be improved?
    Miravitlles M
    Arch Bronconeumol; 2016 Jan; 52(1):1-2. PubMed ID: 26026686
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of chronic obstructive pulmonary disease in Australia after the publication of national guidelines.
    Ta M; George J
    Intern Med J; 2011 Mar; 41(3):263-70. PubMed ID: 20002857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
    Calle Rubio M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease and the NICE guideline.
    Booker R
    Nurs Stand; 2005 Feb 9-15; 19(22):43-52; quiz 54. PubMed ID: 15739646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NICE guidance for COPD.
    Halpin D
    Thorax; 2004 Mar; 59(3):181-2. PubMed ID: 14985544
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic obstructive pulmonary disease guidelines in Europe: a look into the future.
    Miravitlles M; Roche N; Cardoso J; Halpin D; Aisanov Z; Kankaanranta H; Kobližek V; Śliwiński P; Bjermer L; Tamm M; Blasi F; Vogelmeier CF
    Respir Res; 2018 Jan; 19(1):11. PubMed ID: 29347928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COPD diagnosis related to different guidelines and spirometry techniques.
    Nathell L; Nathell M; Malmberg P; Larsson K
    Respir Res; 2007 Dec; 8(1):89. PubMed ID: 18053200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Initiative for Chronic Obstructive Lung Diseases (GOLD).
    Hurd S; Pauwels R
    Pulm Pharmacol Ther; 2002; 15(4):353-5. PubMed ID: 12220939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. It is time for the world to take COPD seriously: a statement from the GOLD board of directors.
    Halpin DMG; Celli BR; Criner GJ; Frith P; López Varela MV; Salvi S; Vogelmeier CF; Chen R; Mortimer K; Montes de Oca M; Aisanov Z; Obaseki D; Decker R; Agusti A
    Eur Respir J; 2019 Jul; 54(1):. PubMed ID: 31273036
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of Australian and international guidelines for grading severity of chronic obstructive pulmonary disease.
    Kyoong A; Mol S; Guy P; Finlay P; Strauss BJ; Holmes P; Bardin PG
    Intern Med J; 2006 Aug; 36(8):506-12. PubMed ID: 16866655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Stratification in Chronic Obstructive Pulmonary Disease. Can the Spanish Guidelines be Improved?
    Golpe R; Suárez-Valor M; Castro-Añón O; Pérez-de-Llano LA
    Arch Bronconeumol (Engl Ed); 2018 Oct; 54(10):533-535. PubMed ID: 29503066
    [No Abstract]   [Full Text] [Related]  

  • 20. [Polish respiratory society guidelines for chronic obstructive pulmonary disease].
    Sliwiński P; Górecka D; Jassem E; Pierzchała W
    Pneumonol Alergol Pol; 2014; 82(3):227-63. PubMed ID: 24793150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.